Why Is Biophytis (BPTS) Stock Up 42% Today?

Biophytis (NASDAQ:BPTS) stock is rocketing higher on Thursday after the company signed a master service agreement with Intsel Chimos.

With this agreement, Intsel Chimos will become the Pharmaceutical Operator/Exploitant in France for Sarconeos. This is in context to the early access program application for the treatment of severe forms of COVID-19.

Stanislas Veillet, CEO of Biophytis, said the following about today’s news.

“Biophytis is part of a very small group of biotechs that have succeeded in developing a treatment that has demonstrated its efficacy in the treatment of severe forms of Covid-19, and now needs to make it available as soon as possible in Europe, the United States and the rest of the world.”

How This Affects BPTS Stock

With this news, Biophytis is opening itself up to bringing its Covid-19 treatment to more areas. That could be a boon for the company as countries continue to deal with new strains of the disease spreading.

It’s also resulted in heavy trading for BPTS stock today. As of this writing, more than 4.5 million shares of the company’s stock have changed hands. That’s a massive jump compared to its daily average trading volume of about 609,000 shares.

BPTS stock is up 42% in pre-market trading on Thursday.

There’s even more stock market news traders will want to read about below!

We’ve got all of the most recent stock market coverage investors need to know about today. That includes the biggest pre-market stock movers this morning, the latest First Solar (NASDAQ:FSLR) news, and more. You can check out all of that news at the following links!

More Thursday Stock Market News

• Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
• 5 Investors Betting Big on First Solar (FSLR) Stock in 2023
• Why Is Hammerhead Energy (HHRS) Stock Up Today?

On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.

With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that  InvestorPlace.com’s writers disclose this fact and warn readers of the risks. 

Read More: Penny Stocks — How to Profit Without Getting Scammed

More From InvestorPlace

• Buy This $5 Stock BEFORE This Apple Project Goes Live
• The Best $1 Investment You Can Make Today
• It doesn’t matter if you have $500 or $5 million. Do this now.

The post Why Is Biophytis (BPTS) Stock Up 42% Today? appeared first on InvestorPlace.

InvestorPlace| InvestorPlace